0001415889-23-000105.txt : 20230103 0001415889-23-000105.hdr.sgml : 20230103 20230103172009 ACCESSION NUMBER: 0001415889-23-000105 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230103 FILED AS OF DATE: 20230103 DATE AS OF CHANGE: 20230103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SULLIVAN LOUIS W CENTRAL INDEX KEY: 0001193522 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 23503290 FORMER NAME: FORMER CONFORMED NAME: SULLIVAN LOUIS DATE OF NAME CHANGE: 20020927 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 4 1 form4-01032023_100100.xml X0306 4 2023-01-03 0001082554 UNITED THERAPEUTICS Corp UTHR 0001193522 SULLIVAN LOUIS W C/O UNITED THERAPEUTICS CORPORATION 1040 SPRING STREET SILVER SPRING MD 20910 true false false false Common Stock 2023-01-03 4 M 0 700 132.30 D 12880 D Common Stock 2023-01-03 4 S 0 700 276.26 D 12180 D Stock Options 132.30 2023-01-03 4 M 0 700 0 D 2018-06-28 2027-06-28 Common Stock 700 1400 D This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. /s/ John S. Hess, Jr. under Power of Attorney 2023-01-03